help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doherty, T. M.
Right arrow Articles by Rajavashisth, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doherty, T. M.
Right arrow Articles by Rajavashisth, T. B.
Endocrine Reviews 25 (4): 629-672
Copyright © 2004 by The Endocrine Society

Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification

Terence M. Doherty, Lorraine A. Fitzpatrick, Daisuke Inoue, Jian-Hua Qiao, Michael C. Fishbein, Robert C. Detrano, Prediman K. Shah and Tripathi B. Rajavashisth

Atherosclerosis Research Center and Burns and Allen Research Institute (T.M.D., P.K.S., T.B.R.), Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center and David Geffen School of Medicine at the University of California Los Angeles (UCLA), Los Angeles, California 90048; Division of Endocrinology, Diabetes, Metabolism, and Nutrition (L.A.F.), Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905; Division of Endocrinology and Metabolism (D.I.), Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima 770-8503, Japan; Department of Pathology and Laboratory Medicine (J.-H.Q., M.C.F.), David Geffen School of Medicine at UCLA, Los Angeles, California 90095; and Division of Cardiology (R.C.D.), Department of Medicine, Harbor-UCLA Research and Education Institute, Torrance, California 90512

Correspondence: Address all correspondence and requests for reprints to: Tripathi B. Rajavashisth, Ph.D., Atherosclerosis Research Center, Davis Research Building, Room 1062, Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California, Los Angeles, 8700 Beverly Boulevard, Los Angeles, California 90048-1865. E-mail: rajavashisth{at}cshs.org

Pathologists have recognized arterial calcification for over a century. Recent years have witnessed a strong resurgence of interest in atherosclerotic plaque calcification because it: 1) can be easily detected noninvasively; 2) closely correlates with the amount of atherosclerotic plaque; 3) serves as a surrogate measure for atherosclerosis, allowing preclinical detection of the disease; and 4) is associated with heightened risk of adverse cardiovascular events. There are two major types of calcification in arteries: calcification of the media tunica layer (sometimes called Mönckeberg’s sclerosis), and calcification within subdomains of atherosclerotic plaque within the intimal layer of the artery. There are important similarities and differences between these two entities. Of particular interest are increasing parallels between cellular and molecular features of arterial calcification and bone biology, and this has led to accelerating interest in understanding how and why bone-like mineral deposits may form in arteries. Here, we review the two major pathological types of arterial calcification, the proposed models of calcification, and endocrine and genetic determinants that affect arterial calcification. In addition, we highlight areas requiring further investigation.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. Atkinson
Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences
J Appl Physiol, November 1, 2008; 105(5): 1643 - 1651.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Gossl, U. I. Modder, E. J. Atkinson, A. Lerman, and S. Khosla
Osteocalcin Expression by Circulating Endothelial Progenitor Cells in Patients With Coronary Atherosclerosis
J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1314 - 1325.
[Abstract] [Full Text] [PDF]


Home page
jvdiHome page
A. Fales-Williams, B. Sponseller, and H. Flaherty
Idiopathic arterial medial calcification of the thoracic arteries in an adult horse
J Vet Diagn Invest, September 1, 2008; 20(5): 692 - 697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Heiss, T. Eckert, A. Aretz, W. Richtering, W. van Dorp, C. Schafer, and W. Jahnen-Dechent
Hierarchical Role of Fetuin-A and Acidic Serum Proteins in the Formation and Stabilization of Calcium Phosphate Particles
J. Biol. Chem., May 23, 2008; 283(21): 14815 - 14825.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Eller, K. Hochegger, G. M. Feuchtner, E. Zitt, I. Tancevski, A. Ritsch, F. Kronenberg, A. R. Rosenkranz, J. R. Patsch, and G. Mayer
Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 321 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Vega, N. M. Maalouf, and K. Sakhaee
The Role of Receptor Activator of Nuclear Factor-{kappa}B (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4514 - 4521.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. F. Kallmes, Y. H. Ding, D. Dai, R. Kadirvel, D. A. Lewis, and H. J. Cloft
A New Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms
Stroke, August 1, 2007; 38(8): 2346 - 2352.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Simionescu, D. T. Simionescu, and N. R. Vyavahare
Osteogenic Responses in Fibroblasts Activated by Elastin Degradation Products and Transforming Growth Factor-{beta}1: Role of Myofibroblasts in Vascular Calcification
Am. J. Pathol., July 1, 2007; 171(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. D.M. Collett, A. P. Sage, J. P. Kirton, M. Y. Alexander, A. P. Gilmore, and A. E. Canfield
Axl/Phosphatidylinositol 3-Kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells
Circ. Res., March 2, 2007; 100(4): 502 - 509.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Post, L. F. Bielak, K. A. Ryan, Y.-C. Cheng, H. Shen, J. A. Rumberger, P. F. Sheedy II, A. R. Shuldiner, P. A. Peyser, and B. D. Mitchell
Determinants of Coronary Artery and Aortic Calcification in the Old Order Amish
Circulation, February 13, 2007; 115(6): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. Christian, P. Y. Liu, S. Harrington, M. Ruan, V. M. Miller, and L. A. Fitzpatrick
Intimal Estrogen Receptor (ER){beta}, But Not ER{alpha} Expression, Is Correlated with Coronary Calcification and Atherosclerosis in Pre- and Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2713 - 2720.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. V. Anand, A. Lahiri, E. Lim, D. Hopkins, and R. Corder
The Relationship Between Plasma Osteoprotegerin Levels and Coronary Artery Calcification in Uncomplicated Type 2 Diabetic Subjects
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1850 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. V. Anand, E. Lim, A. Lahiri, and J. J. Bax
The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects
Eur. Heart J., April 2, 2006; 27(8): 905 - 912.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Morena, N. Terrier, I. Jaussent, H. Leray-Moragues, L. Chalabi, J.-P. Rivory, F. Maurice, C. Delcourt, J.-P. Cristol, B. Canaud, et al.
Plasma Osteoprotegerin Is Associated with Mortality in Hemodialysis Patients
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 262 - 270.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
D. Hamerman
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
QJM, July 1, 2005; 98(7): 467 - 484.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Y. Liu, R. C. Christian, M. Ruan, V. M. Miller, and L. A. Fitzpatrick
Correlating Androgen and Estrogen Steroid Receptor Expression with Coronary Calcification and Atherosclerosis in Men without Known Coronary Artery Disease
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P.E. Norman and J.T. Powell
Vitamin D, Shedding Light on the Development of Disease in Peripheral Arteries
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 39 - 46.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society